|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-12-22
|
|
pubmed:abstractText |
Levosimendan, a novel calcium-dependent calcium sensitizer of the myocardial contractile proteins, also enhances diastolic relaxation and induces peripheral vasodilation by opening potassium channels. To assess the combined energetical effects of levosimendan infusion in vivo, we performed positron emission tomography in patients with decompensated chronic heart failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0009-9236
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
522-31
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11103755-Cardiotonic Agents,
pubmed-meshheading:11103755-Catheterization, Swan-Ganz,
pubmed-meshheading:11103755-Coronary Vessels,
pubmed-meshheading:11103755-Cross-Over Studies,
pubmed-meshheading:11103755-Double-Blind Method,
pubmed-meshheading:11103755-Female,
pubmed-meshheading:11103755-Heart Failure,
pubmed-meshheading:11103755-Hemodynamics,
pubmed-meshheading:11103755-Humans,
pubmed-meshheading:11103755-Hydrazones,
pubmed-meshheading:11103755-Infusions, Intravenous,
pubmed-meshheading:11103755-Male,
pubmed-meshheading:11103755-Middle Aged,
pubmed-meshheading:11103755-Oxygen Consumption,
pubmed-meshheading:11103755-Pyridazines,
pubmed-meshheading:11103755-Tomography, Emission-Computed
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Myocardial efficiency during levosimendan infusion in congestive heart failure.
|
|
pubmed:affiliation |
Department of Medicine, Turku University Hospital and Turku PET Centre, Finland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
